SG169395A1 - Detection of cancer by elevated levels of bcl-2 - Google Patents
Detection of cancer by elevated levels of bcl-2Info
- Publication number
- SG169395A1 SG169395A1 SG201100891-9A SG2011008919A SG169395A1 SG 169395 A1 SG169395 A1 SG 169395A1 SG 2011008919 A SG2011008919 A SG 2011008919A SG 169395 A1 SG169395 A1 SG 169395A1
- Authority
- SG
- Singapore
- Prior art keywords
- bcl
- cancer
- detection
- binds
- protein
- Prior art date
Links
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 title abstract 5
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 3
- 108010090931 Proto-Oncogene Proteins c-bcl-2 Proteins 0.000 abstract 2
- 102000013535 Proto-Oncogene Proteins c-bcl-2 Human genes 0.000 abstract 2
- 210000001124 body fluid Anatomy 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 206010033128 Ovarian cancer Diseases 0.000 abstract 1
- 206010061535 Ovarian neoplasm Diseases 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77167706P | 2006-02-09 | 2006-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG169395A1 true SG169395A1 (en) | 2011-03-30 |
Family
ID=38345845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG201100891-9A SG169395A1 (en) | 2006-02-09 | 2007-02-09 | Detection of cancer by elevated levels of bcl-2 |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US8034549B2 (ru) |
| EP (1) | EP1996940B1 (ru) |
| JP (1) | JP4896994B2 (ru) |
| KR (1) | KR20080114689A (ru) |
| CN (1) | CN101384903A (ru) |
| AT (1) | ATE538386T1 (ru) |
| AU (1) | AU2007212278A1 (ru) |
| BR (1) | BRPI0707645B8 (ru) |
| CA (1) | CA2642051C (ru) |
| IL (1) | IL192866A (ru) |
| NO (1) | NO20083820L (ru) |
| NZ (1) | NZ570008A (ru) |
| RU (1) | RU2436098C2 (ru) |
| SG (1) | SG169395A1 (ru) |
| WO (1) | WO2007092627A2 (ru) |
| ZA (1) | ZA200805787B (ru) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10533998B2 (en) | 2008-07-18 | 2020-01-14 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| US20060078893A1 (en) * | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
| GB0307428D0 (en) * | 2003-03-31 | 2003-05-07 | Medical Res Council | Compartmentalised combinatorial chemistry |
| GB0307403D0 (en) * | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
| US20050221339A1 (en) * | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
| US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
| EP3913375A1 (en) | 2006-01-11 | 2021-11-24 | Bio-Rad Laboratories, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| CN101384903A (zh) | 2006-02-09 | 2009-03-11 | 南佛罗里达大学 | 利用bcl-2水平的增高检测癌肿 |
| EP2021113A2 (en) | 2006-05-11 | 2009-02-11 | Raindance Technologies, Inc. | Microfluidic devices |
| US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
| BRPI0711011A2 (pt) * | 2006-05-18 | 2011-08-23 | Molecular Profiling Inst Inc | método para a determinação da intervenção médica para um estado de doença, método para a identificação de uma terapia de droga com capacidade de interação com um alvo molecular e sistema para a determinação da intervenção médica individualizada para um estado de doença |
| US8768629B2 (en) * | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
| US9012390B2 (en) | 2006-08-07 | 2015-04-21 | Raindance Technologies, Inc. | Fluorocarbon emulsion stabilizing surfactants |
| US8772046B2 (en) | 2007-02-06 | 2014-07-08 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| WO2008130623A1 (en) | 2007-04-19 | 2008-10-30 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| US20100256610A1 (en) * | 2007-10-25 | 2010-10-07 | Basil Rigas | Apparatus and method of detection and localized treatment of abnormal conditions |
| WO2010009365A1 (en) | 2008-07-18 | 2010-01-21 | Raindance Technologies, Inc. | Droplet libraries |
| US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
| EP2338056B1 (en) * | 2008-10-10 | 2018-01-03 | Dana Farber Cancer Institute | Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides |
| WO2010111231A1 (en) | 2009-03-23 | 2010-09-30 | Raindance Technologies, Inc. | Manipulation of microfluidic droplets |
| US8328795B2 (en) * | 2009-04-03 | 2012-12-11 | Candela Corporation | Skin resurfacing at 1930 nm |
| IN2012DN00707A (ru) * | 2009-07-24 | 2015-06-19 | Geadic Biotec Aie | |
| WO2011042564A1 (en) | 2009-10-09 | 2011-04-14 | Universite De Strasbourg | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
| WO2011056688A2 (en) * | 2009-10-27 | 2011-05-12 | Caris Life Sciences, Inc. | Molecular profiling for personalized medicine |
| EP2517025B1 (en) | 2009-12-23 | 2019-11-27 | Bio-Rad Laboratories, Inc. | Methods for reducing the exchange of molecules between droplets |
| EP4484577A3 (en) | 2010-02-12 | 2025-03-26 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
| US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
| EP2622103B2 (en) | 2010-09-30 | 2022-11-16 | Bio-Rad Laboratories, Inc. | Sandwich assays in droplets |
| SG189957A1 (en) * | 2010-11-05 | 2013-06-28 | Morphotek Inc | Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers |
| WO2012109600A2 (en) | 2011-02-11 | 2012-08-16 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
| US9150852B2 (en) | 2011-02-18 | 2015-10-06 | Raindance Technologies, Inc. | Compositions and methods for molecular labeling |
| AU2012222192A1 (en) * | 2011-02-23 | 2013-10-17 | Mdsure Ltd | Compositions and methods for personal tumor profiling treatment |
| US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
| CN103764668B (zh) * | 2011-07-09 | 2016-08-17 | 加利福尼亚大学董事会 | 白血病干细胞靶向配体及应用方法 |
| US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
| WO2013035095A1 (en) * | 2011-09-08 | 2013-03-14 | Ben-Gurion University Of The Negev Research And Development Authority | Methods for diagnosing cancer |
| WO2013044187A2 (en) * | 2011-09-22 | 2013-03-28 | Memorial Sloan-Kettering Cancer Center | Detecting ovarian cancer |
| WO2013059805A1 (en) * | 2011-10-21 | 2013-04-25 | Decimadx, Llc | Point-of care immunoassay for quantitative small analyte detection |
| WO2013120089A1 (en) | 2012-02-10 | 2013-08-15 | Raindance Technologies, Inc. | Molecular diagnostic screening assay |
| WO2013165748A1 (en) | 2012-04-30 | 2013-11-07 | Raindance Technologies, Inc | Digital analyte analysis |
| EP2986762B1 (en) | 2013-04-19 | 2019-11-06 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
| KR102241973B1 (ko) * | 2013-08-19 | 2021-04-19 | 비온테크 디아그노스틱스 게엠베하 | 종양의 분자 서브타이핑을 위한 방법 및 키트 |
| US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
| US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
| US11193176B2 (en) | 2013-12-31 | 2021-12-07 | Bio-Rad Laboratories, Inc. | Method for detecting and quantifying latent retroviral RNA species |
| EP3825411A1 (en) | 2014-06-18 | 2021-05-26 | Clear Gene, Inc. | Methods, compositions, and devices for rapid analysis of biological markers |
| CA2961613A1 (en) | 2014-09-17 | 2016-03-24 | Hologic, Inc. | Method of partial lysis and assay |
| GB201417281D0 (en) * | 2014-09-30 | 2014-11-12 | Ge Healthcare Uk Ltd | Methods and devices relating to the detection of oral cancer biomarkers |
| JP5995117B2 (ja) * | 2015-01-26 | 2016-09-21 | 国立大学法人 筑波大学 | 可溶型ｃｄ１５５タンパク質を用いた癌の検出方法 |
| US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
| US11401558B2 (en) | 2015-12-18 | 2022-08-02 | Clear Gene, Inc. | Methods, compositions, kits and devices for rapid analysis of biological markers |
| US12275994B2 (en) | 2017-06-22 | 2025-04-15 | Clear Gene, Inc. | Methods and compositions for the analysis of cancer biomarkers |
| US10998178B2 (en) | 2017-08-28 | 2021-05-04 | Purdue Research Foundation | Systems and methods for sample analysis using swabs |
| JP2021530247A (ja) * | 2018-07-05 | 2021-11-11 | オベーション ダイアグノスティクス エルエルシー | 癌の診断のためのＢＣｌ−２抗体とイムノアッセイ |
| CN109374897B (zh) * | 2018-11-22 | 2021-11-02 | 大连大学 | 一种用于肝癌检测的试剂盒 |
| AU2020398476A1 (en) * | 2019-12-06 | 2022-07-14 | Proteina, Co., Ltd. | Method for predicting reactivity to drug targeting BCL2 family protein |
| WO2021216691A1 (en) * | 2020-04-21 | 2021-10-28 | Croce Carlo M | Methods of detecting and treating cancers characterized by loss of mir15 and mir16 expression |
| KR20230009377A (ko) * | 2020-05-12 | 2023-01-17 | 론자 휴스턴 아이엔씨. | 아데노-연관 바이러스를 검출하기 위한 방법 및 키트 |
| CN111679076A (zh) * | 2020-06-15 | 2020-09-18 | 吉林医药学院 | 一种用于检测cyclinD1和BCL-2抗体的检测试剂盒 |
| WO2023239572A1 (en) * | 2022-06-01 | 2023-12-14 | Northeastern University | Enhanced specificity mass tag dna adductomics |
| WO2025075824A1 (en) * | 2023-10-02 | 2025-04-10 | Siemens Healthcare Diagnostics Inc. | Urine sediment interface with probabilistic classification binning and methods of producing and using same |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3654090A (en) | 1968-09-24 | 1972-04-04 | Organon | Method for the determination of antigens and antibodies |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
| US4260678A (en) | 1979-02-23 | 1981-04-07 | Corning Glass Works | Determining creatine kinase isoenzmes via immobilized antibody-isoenzyme complexes |
| US4381291A (en) | 1979-02-23 | 1983-04-26 | Ab Fortia | Measurement of free ligands |
| US4343312A (en) | 1979-04-16 | 1982-08-10 | Vitafin N.V. | Pacemaker output circuit |
| FR2455743A1 (fr) | 1979-05-02 | 1980-11-28 | Goella Laboratoires | Procede et dispositif pour le dosage des lipoproteines seriques |
| US4357311A (en) | 1980-10-03 | 1982-11-02 | Warner-Lambert Company | Substrate for immunoassay and means of preparing same |
| US4867973A (en) | 1984-08-31 | 1989-09-19 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
| US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| US4741900A (en) | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
| JPS59500735A (ja) | 1983-04-18 | 1984-04-26 | エス・ア−ル・アイ・インタ−ナシヨナル | 人間の癌診断のための方法および試験キツト |
| US4617261A (en) | 1984-03-21 | 1986-10-14 | Cetus Corporation | Process for labeling nucleic acids and hybridization probes |
| US4582789A (en) | 1984-03-21 | 1986-04-15 | Cetus Corporation | Process for labeling nucleic acids using psoralen derivatives |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5015568A (en) * | 1986-07-09 | 1991-05-14 | The Wistar Institute | Diagnostic methods for detecting lymphomas in humans |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5356817A (en) | 1988-06-09 | 1994-10-18 | Yale University | Methods for detecting the onset, progression and regression of gynecologic cancers |
| US5312922A (en) | 1992-04-06 | 1994-05-17 | Nordion International Inc. | Europium and terbium chelators for time-resolved fluorometric assays |
| CA2158162A1 (en) * | 1993-03-17 | 1994-09-29 | Juan Pedro De Zoeten | Apparatus for the detection of a specifically reacting substance |
| US5539094A (en) * | 1993-11-12 | 1996-07-23 | La Jolla Cancer Research Foundation | DNA encoding Bcl-2-associated proteins |
| US5695944A (en) * | 1995-05-05 | 1997-12-09 | Thomas Jefferson University | Modulation of bcl-2 phosphorylation |
| US6811995B1 (en) | 1996-04-26 | 2004-11-02 | Children's Medical Center Corporation | Non-invasive enzyme screen for cancer |
| US5821082A (en) * | 1996-05-23 | 1998-10-13 | St. Louis University Health Sciences Center | Anti-proliferation domain of a human Bcl-2 and DNA encoding the same |
| DE19936618A1 (de) | 1999-08-04 | 2001-03-15 | Monotec Gmbh | Diagnostisches Kit und dessen Verwendung |
| AU2001233156A1 (en) * | 2000-02-01 | 2001-08-14 | Human Genome Sciences, Inc. | Bcl-2-like polynucleotides, polypeptides, and antibodies |
| KR100414637B1 (ko) * | 2000-02-08 | 2004-01-13 | (주)에스제이바이오메드 | 사람 미토콘드리아 아데닐레이트 키나제 이소자임들에대한 항체와 면역학적 제제 및 심장질환 진단키트 |
| US7279294B2 (en) | 2000-04-03 | 2007-10-09 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services, Nih | Tumor markers in ovarian cancer |
| US6492127B2 (en) * | 2001-01-23 | 2002-12-10 | Varian, Inc. | Lateral flow testing device with on-board chemical reactant |
| EP1456645B1 (en) * | 2001-05-07 | 2007-07-11 | The Burnham Institute | Methods for determining the prognosis for cancer patients using tucan |
| AU2002309668A1 (en) | 2001-05-07 | 2002-11-18 | The Burnham Institute | Methods for determining the prognosis for cancer patients using tucan |
| EP2261368A1 (en) | 2002-03-13 | 2010-12-15 | Genomic Health, Inc. | Gene expression profiling in biopsied tumor tissues |
| KR20030092378A (ko) * | 2002-05-29 | 2003-12-06 | 박영미 | 고형암의 진행 정도를 진단하는 방법 및 키트 |
| AU2003243559A1 (en) * | 2002-06-13 | 2003-12-31 | Neuropro Technologies, Inc. | Apparatus and methods for detecting cerebrospinal fluid |
| CN1402004A (zh) * | 2002-09-27 | 2003-03-12 | 江西中德生物工程有限公司 | 一种免疫层析一步法检测β－肾上腺素激动剂类药物的方法及试纸的制备 |
| US20040137538A1 (en) * | 2003-01-10 | 2004-07-15 | Bradford Sherry A. | Cancer comprehensive assay kit for identifying cancer protein patterns |
| US7288383B2 (en) | 2003-01-15 | 2007-10-30 | The Brigham And Women's Hospital, Inc. | Eosinophil-derived neurotoxin as a marker for ovarian cancer |
| JP2008514966A (ja) * | 2004-09-30 | 2008-05-08 | クイデル コーポレイション | 第１及び第２流路を有する分析装置 |
| CN101384903A (zh) | 2006-02-09 | 2009-03-11 | 南佛罗里达大学 | 利用bcl-2水平的增高检测癌肿 |
-
2007
- 2007-02-09 CN CNA2007800049603A patent/CN101384903A/zh active Pending
- 2007-02-09 SG SG201100891-9A patent/SG169395A1/en unknown
- 2007-02-09 NZ NZ570008A patent/NZ570008A/en unknown
- 2007-02-09 AU AU2007212278A patent/AU2007212278A1/en not_active Abandoned
- 2007-02-09 EP EP07763533A patent/EP1996940B1/en active Active
- 2007-02-09 BR BRPI0707645A patent/BRPI0707645B8/pt not_active IP Right Cessation
- 2007-02-09 JP JP2008554404A patent/JP4896994B2/ja not_active Expired - Fee Related
- 2007-02-09 US US11/704,408 patent/US8034549B2/en active Active
- 2007-02-09 WO PCT/US2007/003608 patent/WO2007092627A2/en not_active Ceased
- 2007-02-09 RU RU2008136193/15A patent/RU2436098C2/ru not_active IP Right Cessation
- 2007-02-09 CA CA2642051A patent/CA2642051C/en active Active
- 2007-02-09 AT AT07763533T patent/ATE538386T1/de active
- 2007-02-09 KR KR1020087019574A patent/KR20080114689A/ko not_active Withdrawn
-
2008
- 2008-07-02 ZA ZA200805787A patent/ZA200805787B/xx unknown
- 2008-07-17 IL IL192866A patent/IL192866A/en not_active IP Right Cessation
- 2008-09-08 NO NO20083820A patent/NO20083820L/no not_active Application Discontinuation
-
2011
- 2011-08-08 US US13/205,095 patent/US20110318763A1/en not_active Abandoned
-
2016
- 2016-05-20 US US15/160,649 patent/US20160258960A1/en not_active Abandoned
-
2018
- 2018-11-14 US US16/190,475 patent/US11156613B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| RU2436098C2 (ru) | 2011-12-10 |
| ATE538386T1 (de) | 2012-01-15 |
| NO20083820L (no) | 2008-11-07 |
| WO2007092627A9 (en) | 2007-10-18 |
| AU2007212278A1 (en) | 2007-08-16 |
| KR20080114689A (ko) | 2008-12-31 |
| RU2008136193A (ru) | 2010-03-20 |
| CA2642051C (en) | 2017-01-24 |
| CN101384903A (zh) | 2009-03-11 |
| CA2642051A1 (en) | 2007-08-16 |
| IL192866A (en) | 2013-04-30 |
| US8034549B2 (en) | 2011-10-11 |
| EP1996940A2 (en) | 2008-12-03 |
| BRPI0707645B8 (pt) | 2021-07-27 |
| US20190072556A1 (en) | 2019-03-07 |
| BRPI0707645A2 (pt) | 2011-05-10 |
| NZ570008A (en) | 2011-10-28 |
| US20160258960A1 (en) | 2016-09-08 |
| WO2007092627A3 (en) | 2008-11-13 |
| US11156613B2 (en) | 2021-10-26 |
| ZA200805787B (en) | 2009-05-27 |
| EP1996940B1 (en) | 2011-12-21 |
| EP1996940A4 (en) | 2009-10-21 |
| BRPI0707645B1 (pt) | 2019-04-09 |
| WO2007092627A2 (en) | 2007-08-16 |
| US20080009005A1 (en) | 2008-01-10 |
| JP2009526234A (ja) | 2009-07-16 |
| US20110318763A1 (en) | 2011-12-29 |
| JP4896994B2 (ja) | 2012-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG169395A1 (en) | Detection of cancer by elevated levels of bcl-2 | |
| WO2008134526A3 (en) | Glycoprotein profiling of bladder cancer | |
| WO2011079938A3 (en) | System and method for determining the concentration of an analyte in a sample fluid | |
| WO2008021290A9 (en) | Organ-specific proteins and methods of their use | |
| DE602005015894D1 (de) | Diagnostische testvorrichtung | |
| PL2073008T3 (pl) | Ulepszone sposoby prowadzenia testów immunologicznych | |
| AU2004256206A1 (en) | Device and method for simultaneous carrying out of blood group determination, serum cross-check and antibody detection test | |
| MY162697A (en) | Methods, devices and kits for detecting or monitoring acute kidney injury | |
| TW200606420A (en) | Biosensors having improved sample application and uses thereof | |
| DE60129151D1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
| NZ602056A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| ATE556030T1 (de) | Ultrasensitiver nachweis von analyten | |
| WO2007075928A3 (en) | Integrated patch and assay device with visual detection means | |
| TW200720441A (en) | New labelling strategies for the sensitive detection of analytes | |
| WO2010051544A3 (en) | Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer | |
| WO2009020782A3 (en) | Oral fluid assays for the detection of heavy metal exposure | |
| WO2007059065A3 (en) | Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia | |
| WO2007030949A3 (en) | Methods of diagnosing ovarian cancer and kits therefor | |
| WO2005124356A3 (en) | Use of protein cbp2 as a marker for colorectal cancer | |
| WO2005116234A3 (en) | Detection and quantification of intracellular pathogens | |
| WO2008072192A3 (en) | Biological assay substrate and method and device for producing such substrate | |
| WO2007061940A3 (en) | Method for detecting an inflammatory disease or cancer | |
| SI1977244T1 (sl) | Razlikovanje med bakterijskim meningitisom in virusnim meningitisom | |
| WO2008025481A8 (en) | Sensitive method for detecting circular telomeric molecules and its application in cancer diagnostics and treatment | |
| WO2006089219A3 (en) | Neoepitope detection of disease using protein arrays |